MCM
ANAC

Matarin Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Matarin Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,661
Closed -$1.37M – 247
2015
Q3 		$1.37M Sell
11,661
-248
-2% -$32.4K 0.28% 117
2015
Q2 		$922K Buy
11,909
+8,012
+206% +$525K 0.26% 133
2015
Q1 		$225K Buy
+3,897
New +$165K 0.07% 179

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Matarin Capital Management's ANAC Position: Q4 2015 in Review

Matarin Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2015, closing a stake of 11,661 shares — an estimated $1.37M sold.

Matarin Capital Management first reported a position in ANAC in Q1 2015 and held it in 3 quarters. The position peaked at $1.37M in Q3 2015. 214 funds tracked by Wall St. Rank hold ANAC as of Q4 2015.

  • Matarin Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2015 after selling out during the quarter.
  • Matarin Capital Management sold 11,661 ANACOR PHARMACEUTICALS INC COM shares in Q4 2015, an estimated $1.37M.
  • Matarin Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 3 quarters.
  • Matarin Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $1.37M in Q3 2015.
  • 214 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2015.

Based on Matarin Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.